- Home
- XPON vs ALZN Comparison
XPON vs ALZN Comparison
Compare XPON & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPON
- ALZN
- Stock Information
- Founded
- XPON 2016
- ALZN 2016
- Country
- XPON United States
- ALZN United States
- Employees
- XPON N/A
- ALZN N/A
- Industry
- XPON Electronic Components
- ALZN Medicinal Chemicals and Botanical Products
- Sector
- XPON Technology
- ALZN Health Care
- Exchange
- XPON Nasdaq
- ALZN Nasdaq
- Market Cap
- XPON 3.2M
- ALZN 2.6M
- IPO Year
- XPON 2022
- ALZN 2021
- Fundamental
- Price
- XPON $0.83
- ALZN $2.93
- Analyst Decision
- XPON
- ALZN Strong Buy
- Analyst Count
- XPON 0
- ALZN 1
- Target Price
- XPON N/A
- ALZN $180.00
- AVG Volume (30 Days)
- XPON 54.1K
- ALZN 711.6K
- Earning Date
- XPON 08-13-2025
- ALZN 07-29-2025
- Dividend Yield
- XPON N/A
- ALZN N/A
- EPS Growth
- XPON N/A
- ALZN N/A
- EPS
- XPON N/A
- ALZN N/A
- Revenue
- XPON $6,702,411.00
- ALZN N/A
- Revenue This Year
- XPON $61.26
- ALZN $322.64
- Revenue Next Year
- XPON N/A
- ALZN N/A
- P/E Ratio
- XPON N/A
- ALZN N/A
- Revenue Growth
- XPON 23.07
- ALZN N/A
- 52 Week Low
- XPON $0.60
- ALZN $2.75
- 52 Week High
- XPON $120.00
- ALZN $135.54
- Technical
- Relative Strength Index (RSI)
- XPON 43.08
- ALZN 36.96
- Support Level
- XPON $0.81
- ALZN $2.75
- Resistance Level
- XPON $0.97
- ALZN $3.07
- Average True Range (ATR)
- XPON 0.08
- ALZN 0.19
- MACD
- XPON -0.01
- ALZN 0.05
- Stochastic Oscillator
- XPON 18.57
- ALZN 19.66
About XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.